By Alexander Bueso
Date: Monday 14 Sep 2020
(Sharecast News) - European stocks finished the session on a mixed note, despite news at the weekend that AstraZeneca has resumed the key clinical trial for the Covid-19 vaccine candidate that it's developing with the University of Oxford.
No recent information was found.
Currency | Euro |
Share Price | 266.80 |
Change Today | -13.00 |
% Change | -4.65 % |
52 Week High | 316.40 |
52 Week Low | 162.20 |
Volume | 207,644 |
Shares Issued | 8.35m |
Market Cap | 2,227.43m |
Beta | 0.62 |
Time | Volume / Share Price |
17:35 | 404 @ 266.80 |
17:35 | 230 @ 266.80 |
17:35 | 340 @ 266.80 |
17:35 | 12 @ 266.80 |
17:35 | 148 @ 266.80 |
You are here: research